The current public health crisis has deployed resources to prevent further infection and to treat those that are infected. This has severely restricted available supplies and personnel thus disrupting other activities of the health sector, such as NTD elimination programs. Around the globe, NTD control programs have been postponed, pushing back mass drug administration (MDA) campaigns. Consequently, disease interventions that involve preventative chemotherapy are temporarily absent, causing certain NTDs to remain untreated.